Current trends in pharmacovigilance: value and gaps of patient reporting
- 91 Downloads
The World Health Organization (WHO) defines pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any drug-related problems . Broadly speaking, this definition relates to a system used for adverse drug reaction (ADR) reporting and, having detected a potential problem, minimize its impact in the population. This is done using the spontaneous reporting system (SRS), in which a healthcare professional (HCP) or patient sends an unsolicited communication to competent authorities or pharmaceutical companies describing one or more ADRs . However, pharmacovigilance is much more than just spontaneous reporting (SR) . Its scope has grown considerably in the past few decades, encompassing not only ADR reporting but as well medication errors (ME), counterfeit or substandard medicines, lack of efficacy or drug–drug interactions . Currently, pharmacovigilance covers the life-cycle of a...
No funding was provided for the completion of this commentary.
Conflicts of interest
Authors have completed the conflict of interest disclosure form and declare no financial relationships with any organizations that might have an interest in the submitted work. There are no other relationships or activities that could appear to have influenced the submitted work. Authors have no support from any organization for the submitted work.
- 1.World Health Organization. The Importance of Pharmacovigilance: safety monitoring of medicinal products (2002). http://apps.who.int/medicinedocs/en/d/Js4893e/. Assessed 19 Dec 2017.
- 10.Watson S, Chandler RE, Taavola H, Härmark L, Grundmark B, Zekarias A, et al. Safety concerns reported by patients identified in a collaborative signal detection workshop using vigibase: results and reflections from lareb and uppsala monitoring centre. Drug Saf. 2018;41:203–12.CrossRefPubMedGoogle Scholar
- 15.Jadeja M, Inglefield P. An evaluation of the EU wide social media campaign to raise awareness of national spontaneous ADR reporting systems (2017). http://www.scopejointaction.eu/_assets/files/2017-01-17-SCOPE-ADR-social-media-campaign-evaluation-FINAL-Mitul-Jadeja.pdf. Assessed 14 Dec 2017.
- 27.Defer G, Le Caignec F, Fedrizzi S, Montastruc F, Chevanne D, Parienti J-J, et al. Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial. Trials BioMed Cent. 2018;19:174.Google Scholar